Abstract
Tyrosinase (EC 1.14.18.1) is known to be the rate-limiting enzyme responsible for catalyzing the first two steps in the synthesis of melanin pigments that determine the coloring of hair, skin and eyes. Tyrosinase catalyzes two- sequence distinct bio-reactions in pigment productions: L-tyrosine to L-dopa (hydroxylation); and L-dopa to dopaquinone (oxidation). The inhibition of tyrosinase has been established as one of the major strategies to regulate the production of melanin and the inhibitors are used to treat hyper-pigmentation and other unwanted effects from melanogenesis. There are now a variety of medicaments inhibiting melanin synthesis to treat excess melanin production or hyper-pigmentation of human skin, including the usage of natural plant extracts or chemically synthesized compounds. Recently, due to an increasing emphasis on healthy concepts, attention has been drawn to the usage of naturally produced crude materials and drugs in cosmetics and pharmaceutical applications. In this review, we demonstrate melanogenic inhibitory factors such as flavonoids, stilbenes, simple phenolics, furans, triterpenes, alkaloids, and other synthetic compounds. The structure-activity relationships are classified in terms of their inhibition of tyrosinase functions and copper chelating activity.
Keywords: Alkaloids, flavonoids, furans, melanin, tyrosinase inhibitor, stilbenes, simple phenolics, triterpenes.
Current Organic Chemistry
Title:An Updated Organic Classification of Tyrosinase Inhibitors on Melanin Biosynthesis
Volume: 19 Issue: 1
Author(s): Chung-Yi Chen, Li-Ching Lin, Wen-Feng Yang, Jennifer Bordon and Hui-Min D. Wang
Affiliation:
Keywords: Alkaloids, flavonoids, furans, melanin, tyrosinase inhibitor, stilbenes, simple phenolics, triterpenes.
Abstract: Tyrosinase (EC 1.14.18.1) is known to be the rate-limiting enzyme responsible for catalyzing the first two steps in the synthesis of melanin pigments that determine the coloring of hair, skin and eyes. Tyrosinase catalyzes two- sequence distinct bio-reactions in pigment productions: L-tyrosine to L-dopa (hydroxylation); and L-dopa to dopaquinone (oxidation). The inhibition of tyrosinase has been established as one of the major strategies to regulate the production of melanin and the inhibitors are used to treat hyper-pigmentation and other unwanted effects from melanogenesis. There are now a variety of medicaments inhibiting melanin synthesis to treat excess melanin production or hyper-pigmentation of human skin, including the usage of natural plant extracts or chemically synthesized compounds. Recently, due to an increasing emphasis on healthy concepts, attention has been drawn to the usage of naturally produced crude materials and drugs in cosmetics and pharmaceutical applications. In this review, we demonstrate melanogenic inhibitory factors such as flavonoids, stilbenes, simple phenolics, furans, triterpenes, alkaloids, and other synthetic compounds. The structure-activity relationships are classified in terms of their inhibition of tyrosinase functions and copper chelating activity.
Export Options
About this article
Cite this article as:
Chen Chung-Yi, Lin Li-Ching, Yang Wen-Feng, Bordon Jennifer and D. Wang Hui-Min, An Updated Organic Classification of Tyrosinase Inhibitors on Melanin Biosynthesis, Current Organic Chemistry 2015; 19 (1) . https://dx.doi.org/10.2174/1385272819666141107224806
DOI https://dx.doi.org/10.2174/1385272819666141107224806 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nuclear Factor Kappa B: A Potential Target for Anti-HIV Chemotherapy
Current Medicinal Chemistry Generation of Human Single-chain Antibody to the CD99 Cell Surface Determinant Specifically Recognizing Ewing’s Sarcoma Tumor Cells
Current Pharmaceutical Biotechnology Recent Advancements in 1,4-Disubstituted 1H-1,2,3-Triazoles as Potential Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Estrogens and Colorectal Cancer
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Plant Extracts as a Natural Source of Bioactive Compounds and Potential Remedy for the Treatment of Certain Skin Diseases
Current Pharmaceutical Design A Review of Studies on Targeting Interleukin 4 Receptor for Central Nervous System Malignancy
Current Molecular Medicine Honey as a Source of Dietary Antioxidants: Structures, Bioavailability and Evidence of Protective Effects Against Human Chronic Diseases
Current Medicinal Chemistry Sphingolipids in Cell Signaling: Their Function as Receptor Ligands, Second Messengers, and Raft Constituents
Current Immunology Reviews (Discontinued) Construction and Analysis of mRNA and lncRNA Regulatory Networks Reveal the Key Genes Associated with Prostate Cancer Related Fatigue During Localized Radiation Therapy
Current Bioinformatics Molecular Mistletoe Therapy: Friend or Foe in Established Anti-Tumor Protocols? A Multicenter, Controlled, Retrospective Pharmaco-Epidemiological Study in Pancreas Cancer
Current Molecular Medicine Utility of Assessing Thiopurine S-methyltransferase Polymorphisms Before Azathioprine Therapy
Current Drug Metabolism The p53-Estrogen Receptor Loop in Cancer
Current Molecular Medicine Muscular Gene Transfer Using Nonviral Vectors
Current Gene Therapy MicroRNA Regulation of Androgen Receptor in Castration-Resistant Prostate Cancer: Premises, Promises, and Potentials
Current Molecular Pharmacology Nanoparticles: Properties and Applications in Cancer Immunotherapy
Current Pharmaceutical Design Protease Inhibitors in the Clinic
Medicinal Chemistry Role of Plasmacytoid Dendritic Cells in Lung-Associated Inflammation
Recent Patents on Inflammation & Allergy Drug Discovery Oncoproteomics of Neuroblastoma: A Blueprint for Future Progress
Current Proteomics Metal Complexes, their Cellular Targets and Potential for Cancer Therapy
Current Pharmaceutical Design Recent Developments on Thiourea Based Anticancer Chemotherapeutics
Anti-Cancer Agents in Medicinal Chemistry